# ICU Medical Inc (ICUI) insider trading

> In the 12 months to Nov 1, 2026, 7 ICUI insiders reported open-market sales of $8.3M across 13 filings; no open-market purchases were filed.

Canonical: https://massive.com/quote/icui/insider-trading
Latest filing: 2026-09-03 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $8.3M | 13 filings · 7 insiders |
| Open-market purchases | $0 | 0 filings |
| Pre-arranged sales (10b5-1) | 3 of 13 | $3.5M of $8.3M sold (43%) |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Brian Michael Bonnell | Chief Financial Officer | $2.7M | — | 2 | 100% of sales | 2026-09-01 |
| Daniel Woolson | VP, GM-Infusion Capital → President | $1.7M | — | 3 | — | 2026-08-13 |
| Christian B. Voigtlander | Chief Operating Officer | $1.6M | — | 1 | — | 2026-08-11 |
| Virginia Ruth Sanzone | VP, General Counsel | $1.3M | — | 3 | 65% of sales | 2026-09-03 |
| Ben Sousa | Chief Information Officer | $401.2K | — | 1 | — | 2026-08-12 |
| David C. Greenberg | Director | $297.9K | — | 1 | — | 2026-05-13 |
| Elisha W. Finney | Director | $249.4K | — | 2 | — | 2026-08-11 |

## Open-market trades by filing

13 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-09-03 | 2026-09-03 | Virginia Ruth Sanzone | VP, General Counsel | Sale (10b5-1) | 4,856 | $168.69 | $819.2K | 16,020 | — |
| 2026-09-01 | 2026-09-01 | Brian Michael Bonnell | Chief Financial Officer | Sale (10b5-1) | 6,381 | $175.00 | $1.1M | 56,062 | — |
| 2026-08-31 | 2026-08-31 | Brian Michael Bonnell | Chief Financial Officer | Sale (10b5-1) | 9,307 | $172.79 | $1.6M | 63,556 | — |
| 2026-08-13 | 2026-08-13 | Daniel Woolson | VP, GM-Infusion Capital | Sale | 5,417 | $181.33 | $982.3K | 17,062 | — |
| 2026-08-12 | 2026-08-12 | Ben Sousa | Chief Information Officer | Sale | 2,250 | $178.32 | $401.2K | 3,076 | — |
| 2026-08-11 | 2026-08-11 | Elisha W. Finney | Director | Sale | 378 | $182.48 | $69.0K | 4,871 | — |
| 2026-08-11 | 2026-08-11 | Christian B. Voigtlander | Chief Operating Officer | Sale | 8,929 | $182.93 | $1.6M | 37,377 | — |
| 2026-05-22 | 2026-05-22 | Daniel Woolson | President | Sale | 2,123 | $132.21 | $280.7K | 22,479 | — |
| 2026-05-15 | 2026-05-14 | Virginia Ruth Sanzone | VP, General Counsel | Sale | 2,447 | $124.08 | $303.6K | 19,460 | — |
| 2026-05-13 | 2026-05-12 | David C. Greenberg | Director | Sale | 2,424 | $122.91 | $297.9K | 7,960 | — |
| 2025-11-25 | 2025-11-25 | Daniel Woolson | VP, GM-Infusion Capital | Sale | 2,897 | $152.35 | $441.4K | 11,297 | — |
| 2025-11-12 | 2025-11-11 | Elisha W. Finney | Director | Sale | 1,285 | $140.42 | $180.4K | 3,995 | — |
| 2025-11-12 | 2025-11-11 | Virginia Ruth Sanzone | VP, General Counsel | Sale | 930 | $142.35 | $132.4K | 5,456 | — |

## Other insider activity (not market trades)

- Option exercises: 33 records
- Tax withholding: 25 records
- Other: 1 record

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Pre-arranged (10b5-1)**: The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- **Role**: The title on each filing. Someone whose title changed shows more than one.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

## FAQ

### Has ICU Medical Inc's CEO sold stock?

No. Vivek Jain (CEO) made no open-market sales filed as CEO in the last 12 months.

### How current is ICUI’s insider data?

These are ICUI Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The ICUI Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=ICUI&filing_date.gte=2025-11-01&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [ICU Medical Inc (ICUI) stock price](https://massive.com/quote/icui.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms